# Image Guided Surgery in Sinonasal Inverted Papilloma

> **NCT03925285** · PHASE1 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 6 (actual)

## Conditions studied

- Inverted Papilloma
- Molecular Fluorescence Imaging

## Interventions

- **DRUG:** Bevacizumab-800CW

## Key facts

- **NCT ID:** NCT03925285
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-06
- **Primary completion:** 2021-07-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03925285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03925285, "Image Guided Surgery in Sinonasal Inverted Papilloma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03925285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*